Tackling the Hepatitis C Disease Burden in Punjab, India
- PMID: 27746619
- PMCID: PMC5052426
- DOI: 10.1016/j.jceh.2016.09.005
Tackling the Hepatitis C Disease Burden in Punjab, India
Abstract
Hepatitis C virus (HCV) is a globally prevalent pathogen and is a major cause of healthcare burden in India. HCV poses a significant problem in the state of Punjab, India owing to the higher prevalence of risk factors like unsafe medical practices (including unsafe injections and dental procedures) and intravenous drug use. The reported prevalence of HCV in this part of the country was 5.2% in 2012, while a recent study has shown the prevalence to be 3.2% in 2016. Similar to the other geographic belts in India, genotype 3 predominates in the state of Punjab. Control of HCV infection in Punjab requires focusing on several strategies. There is a need to formulate a health educational curriculum targeting not only the high-risk population but also the general population regarding the transmission of HCV. Training of family physicians who form the first link to patients in the community is imperative in the success of healthcare programmes. Adopting the dual approach of treating the old cases (decreasing the reservoir pool of HCV) and decreasing the incidence of new ones would help curtail the disease and decrease liver related mortality. A commendable initiative has been launched by the Punjab state government to eliminate HCV from Punjab. However, besides the initiative by the government, a concerted effort by all other stakeholders in managing the HCV burden in India, namely the doctors, the drug companies and the non-government organizations is required for control of HCV.
Keywords: BPL, below poverty line; DNDi, drugs for neglected diseases initiative; ECHO, Extension for Community Healthcare Outcomes; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HCW, health care worker; HD, hemodialysis; INASL, Indian National Association for study of the Liver; IVDU, intravenous drug user; MMPHCRF, Mukh Mantri Punjab Hepatitis-C Relief Fund; NAT, nucleic acid testing; NGO, non-government organization; PSACS, Punjab State AIDS Control Society; Punjab; control; hepatitis C; prevalence.
Figures
Similar articles
-
Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.EClinicalMedicine. 2021 Oct 17;41:101148. doi: 10.1016/j.eclinm.2021.101148. eCollection 2021 Nov. EClinicalMedicine. 2021. PMID: 34712928 Free PMC article.
-
Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?J Clin Exp Hepatol. 2017 Sep;7(3):253-261. doi: 10.1016/j.jceh.2017.08.003. Epub 2017 Sep 23. J Clin Exp Hepatol. 2017. PMID: 28970713 Free PMC article. Review.
-
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 9. J Clin Exp Hepatol. 2014. PMID: 25755548 Free PMC article. Review.
-
Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India.J Nat Sci Biol Med. 2016 Jan-Jun;7(1):72-4. doi: 10.4103/0976-9668.175076. J Nat Sci Biol Med. 2016. PMID: 27003974 Free PMC article.
-
Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.Bull World Health Organ. 1999;77(10):801-7. Bull World Health Organ. 1999. PMID: 10593027 Free PMC article.
Cited by
-
Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.BMJ Open. 2021 Feb 15;11(2):e042280. doi: 10.1136/bmjopen-2020-042280. BMJ Open. 2021. PMID: 33589457 Free PMC article.
-
Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection.BMC Health Serv Res. 2023 Aug 11;23(1):849. doi: 10.1186/s12913-023-09777-x. BMC Health Serv Res. 2023. PMID: 37568106 Free PMC article. Review.
-
Epidemiology of Liver Diseases in India.Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):114-117. doi: 10.1002/cld.1177. eCollection 2022 Mar. Clin Liver Dis (Hoboken). 2022. PMID: 35355840 Free PMC article. Review.
-
Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.Int J Drug Policy. 2018 Jul;57:51-60. doi: 10.1016/j.drugpo.2018.03.023. Epub 2018 Apr 19. Int J Drug Policy. 2018. PMID: 29679811 Free PMC article.
-
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228. doi: 10.1016/S2468-1253(19)30342-5. Epub 2019 Dec 15. Lancet Gastroenterol Hepatol. 2020. PMID: 31852635 Free PMC article. Review.
References
-
- Gower E., Estes C., Blach S., Razavi-Shearer K., Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 suppl):S45–S57. - PubMed
-
- Hissar S.S., Goyal A., Kumar M. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol. 2006;78(4):452–458. - PubMed
-
- Raghuraman S., Shaji R.V., Sridharan G. Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol. 2003;26(1):61–69. - PubMed
-
- Alter H.J., Seeff L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000;20(1):17–35. - PubMed
-
- Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–1342. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources